- Forums
- ASX - By Stock
- EMD
- Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial, page-3
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.002(6.25%) |
Mkt cap ! $14.12M |
Open | High | Low | Value | Volume |
3.4¢ | 3.6¢ | 3.4¢ | $8.332K | 243.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 208187 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 235000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 208187 | 0.032 |
4 | 119518 | 0.031 |
11 | 1281877 | 0.030 |
2 | 82000 | 0.029 |
1 | 5000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 235000 | 2 |
0.040 | 15000 | 1 |
0.041 | 32255 | 1 |
0.042 | 64500 | 1 |
0.043 | 12000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online